Should We Taper or not: A Short Glance to a Dilemma

Creative Commons License

KULA S., Aykut M., Guler G., Sevik D.

GAZI MEDICAL JOURNAL, cilt.29, sa.1, ss.85-86, 2018 (ESCI) identifier identifier

  • Yayın Türü: Makale / Editöre Mektup
  • Cilt numarası: 29 Sayı: 1
  • Basım Tarihi: 2018
  • Doi Numarası: 10.12996/gmj.2018.24
  • Dergi Adı: GAZI MEDICAL JOURNAL
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.85-86
  • Gazi Üniversitesi Adresli: Evet

Özet

The treatment of the acute inflammatory manifestations of acute rheumatic fever (ARF) refers to the utilization of anti-inflammatory agents. Based upon clinical experience, acetylsalicylic acid (ASA) has been traditionally accepted as the first-line therapy for arthritis. However, various scientific sources indicate different schedules for the administration of ASA treatment and such differences may cause misunderstandings. This student study aims to investigate the approaches for the ASA treatment that have been adopted by the pediatric cardiologists in the treatment of ARF arthritis by means of a pre-designed questionnaire.